Biodesix, Inc.
US ˙ NASDAQGM ˙ US09075X1081 ˙ Mortgage Finance

SecurityBDSX / Biodesix, Inc.
InstitutionFSMAX - Fidelity Extended Market Index Fund
Latest Disclosed Ownership22,402 shares
Latest Disclosed Value $ 343,422
FSMAX - Fidelity Extended Market Index Fund ownership in BDSX / Biodesix, Inc.

IMPORTANT: This company has reported a 20 to 1 reverse split as of 2025-09-15. The ownership data on this page IS NOT adjusted for this split. It is incumbent upon the reader to determine if this split affects this data and adjust the figures appropriately. Our engineering team is working on a solution to provide split-adjusted figures in the future.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-02-28 NP BIODESIX EC US09075X2071 22,402 3,010 15.52 343 114.38 0.0008
2026-01-23 2025-11-30 NP BIODESIX EC US09075X2071 19,392 -373,500 -95.06 161 -4.19 0.0004
2025-10-28 2025-08-31 NP BIODESIX EC US09075X1081 392,892 -5,479 -1.38 168 39.17 0.0004
2025-07-24 2025-05-31 NP BIODESIX EC US09075X1081 398,371 1,080 0.27 120 -61.90 0.0003
2025-04-25 2025-02-28 NP BIODESIX EC US09075X1081 397,291 -11,874 -2.90 315 -46.52 0.0008
2025-01-27 2024-11-30 NP BIODESIX EC US09075X1081 409,165 62,295 17.96 589 -13.25 0.0013
2024-10-29 2024-08-31 NP BIODESIX EC US09075X1081 346,870 138,379 66.37 680 127.85 0.0016
2024-07-26 2024-05-31 NP BIODESIX EC US09075X1081 208,491 -2,481 -1.18 298 -8.02 0.0008
2024-04-24 2024-02-29 NP BIODESIX EC US09075X1081 210,972 77,376 57.92 325 62.81 0.0008
2024-01-24 2023-11-30 NP BIODESIX EC US09075X1081 133,596 -95,736 -41.75 199 -44.72 0.0006
2023-10-27 2023-08-31 NP BIODESIX EC US09075X1081 229,332 68,202 42.33 360 60.00 0.0011
2023-07-26 2023-05-31 NP BIODESIX EC US09075X1081 161,130 101,333 169.46 226 82.93 0.0008
2023-04-27 2023-02-28 NP BIODESIX EC US09075X1081 59,797 -249 -0.41 123 2.50 0.0004
2023-01-26 2022-11-30 NP BIODESIX EC US09075X1081 60,046 -94 -0.16 120 6.19 0.0004
2022-10-26 2022-08-31 NP BIODESIX EC US09075X1081 60,140 14,614 32.10 114 68.66 0.0004
2022-07-29 2022-05-31 NP BIODESIX EC US09075X1081 45,526 0 0.00 67 -37.96 0.0002
2022-04-27 2022-02-28 NP BIODESIX EC US09075X1081 45,526 19,385 74.16 108 -39.33 0.0003
2022-01-25 2021-11-30 NP BIODESIX EC US09075X1081 26,141 3,041 13.16 178 -14.42 0.0004
2021-10-26 2021-08-31 NP BIODESIX EC US09075X1081 23,100 2,052 9.75 208 -31.58 0.0005
2021-07-22 2021-05-31 NP BIODESIX EC US09075X1081 21,048 0 0.00 304 -26.75 0.0008
2021-04-23 2021-02-28 NP BIODESIX EC US09075X1081 21,048 21,048 415 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.